Patent ID: 9675572
Date: 2017-06-13
CPC Classifications: A61K,A61P

Claim:
1. A method of treating a subject suffering from traumatic brain injury, spinal cord injury and/or stroke comprising intravenously administering a pharmaceutical composition in an amount effective to reduce inflammation in the brain and/or spinal cord of the subject, wherein the pharmaceutical composition is a stable intravenous pharmaceutical composition comprising: a. an oil phase comprising b. about 12 g/L of egg yolk phospholipids as an emulsifier, and c. an aqueous phase comprising about 25 g/L of glycerol and about 100 mg/L of α-tocopherol, wherein the oil and aqueous phase form a 20% oil in water emulsion, and wherein the omega-3 essential fatty acid is in a concentration of about 50% to about 90% by weight of the oil phase, and wherein omega-6 fatty acids are absent.